Skip to content


Pifeltro (doravirine) is a small molecule pharmaceutical. Doravirine was first approved as Pifeltro on 2018-08-30. It is used to treat hiv-1 in the USA. It has been approved in Europe to treat HIV infections. Delstrigo's patent is valid until 2031-10-07 (FDA).
Trade Name Pifeltro
Common Name Doravirine
Indication hiv infections, hiv-1
Drug Class Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives
Get full access now